Novanta Inc. Common Stock (NOVT) — Analysis Summary
Novanta Inc. Common Stock (NOVT) has a market cap of $5.22B with year-over-year revenue growth of +3.3%. Net margin stands at 5.5%. The stock trades at a P/E ratio of 97.2.
Key Takeaways
- Revenue changed +3.3% year-over-year
- Net margin of 5.5%
- P/E ratio of 97.2
Compared to other companies in the MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES sector, NOVT posted revenue growth of +3.3% and trades at a P/E of 97.2.
Novanta Inc. Common Stock (NOVT)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Sector
MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES
Employees
3,000
Headquarters
BEDFORD, MA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.